or Try an Advanced Search...

    Technical Analysis for TCRT - Alaunos Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.65 -6.87% -0.05
    TCRT closed down 6.87 percent on Monday, July 1, 2024, on 1.13 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical TCRT trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Inside Day Range Contraction -6.87%
    Wide Bands Range Expansion -6.87%
    Oversold Stochastic Weakness -6.87%
    Outside Day Range Expansion -9.58%
    Wide Bands Range Expansion -9.58%
    Oversold Stochastic Weakness -9.58%
    Older End-of-Day Signals for TCRT ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 7 hours ago
    Down 3% about 7 hours ago
    Fell Below Previous Day's Low about 7 hours ago
    Down 2 % about 7 hours ago
    Down 1% about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TCRT Chart by TradingView
    Basic chart:

    Profile

    Alaunos is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR. The Company has clinical and strategic collaborations with The University of Texas MD Anderson Cancer Center and the National Cancer Institute.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cell Therapy Epidermal Growth Factor Receptor Oncogenes National Cancer Institute P53 Tumor Suppressor Genes Ras Gtpase Mm 151 University Of Texas Md Anderson Cancer Center

    Is TCRT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.7235
    52 Week Low 0.61
    Average Volume 40,415
    200-Day Moving Average 1.49
    50-Day Moving Average 1.07
    20-Day Moving Average 0.87
    10-Day Moving Average 0.72
    Average True Range 0.10
    RSI (14) 31.03
    ADX 49.47
    +DI 6.99
    -DI 25.53
    Chandelier Exit (Long, 3 ATRs) 0.85
    Chandelier Exit (Short, 3 ATRs) 0.91
    Upper Bollinger Bands 1.22
    Lower Bollinger Band 0.53
    Percent B (%b) 0.18
    BandWidth 79.52
    MACD Line -0.13
    MACD Signal Line -0.12
    MACD Histogram -0.0096
    Fundamentals Value
    Market Cap 10.44 Million
    Num Shares 16 Million
    EPS -2.25
    Price-to-Earnings (P/E) Ratio -0.29
    Price-to-Sales 2277.94
    Price-to-Book 2.70
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.73
    Resistance 3 (R3) 0.73 0.72 0.71
    Resistance 2 (R2) 0.72 0.70 0.71 0.71
    Resistance 1 (R1) 0.68 0.69 0.68 0.68 0.71
    Pivot Point 0.67 0.67 0.66 0.66 0.67
    Support 1 (S1) 0.63 0.65 0.63 0.63 0.60
    Support 2 (S2) 0.62 0.64 0.61 0.59
    Support 3 (S3) 0.58 0.62 0.59
    Support 4 (S4) 0.58